Serum level of cathelicidin LL-37 is increased in euthymic patients with bipolar disorder irrespective of their cardio-metabolic status
Arch. Clin. Psychiatry (Impr.)
;
46(3): 66-71, May.-June 2019. tab
Artículo
en Inglés
| LILACS
| ID: biblio-1011150
ABSTRACT
Abstract Background Antimicrobial peptides are components of the innate immune system. Cathelicidin LL-37 plays an important role in antimicrobial defense, exerts proinflammatory effect and strongly affects the immune system functioning. Our recent study revealed that serum concentration of LL-37 is increased in patients with bipolar disorder. Objectives The aim of this study is to re-evaluate serum LL-37 levels in patients with euthymic bipolar disorder and in healthy controls, matched for anthropometric and body composition parameters. Methods 36 adult patients with euthymic bipolar disorder and 68 non-depressed adults were included into the study. Concentration of LL-37 in serum was assessed using ELISA method. Detailed anthropometric measurements, body composition and biochemical analyses were performed. Results There was a statistically significant difference (p = 0.01) in serum LL-37 level between patients with bipolar disorder (4.97 ± 7.98 ng/mL) and control subjects (1.78 ± 2.69 ng/mL). Discussion Results of this study indicate that LL-37 serum level is increased in euthymic bipolar disorder patients. We found that this increase could not be attributed to analyzed anthropometric or body composition parameters.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Trastorno Bipolar
/
Composición Corporal
/
Catelicidinas
Límite:
Adulto
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Arch. Clin. Psychiatry (Impr.)
Asunto de la revista:
Psiquiatria
Año:
2019
Tipo del documento:
Artículo
/
Documento de proyecto
País de afiliación:
Polonia
Institución/País de afiliación:
Medical University of Łódz8/PL
Similares
MEDLINE
...
LILACS
LIS